Evidence map›Paper›PMID 40859353›Full record

ArticleRespiratory research2025

Atypical mesenchyme in congenital pulmonary airways malformation: a promising new focus.

Pascal Azar, Yannick Avila, Anita Hiltbrunner, Christophe Delacourt, Anne-Laure Rougemont, Isabelle Vidal, Marie-Luce Bochaton-Piallat, Isabelle Ruchonnet-Metrailler

Abstract read
In one paragraph

Article in Respiratory research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Pascal AzarDepartment of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Yannick AvilaDepartment of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Anita HiltbrunnerDepartment of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Christophe DelacourtPediatric Pulmonology Unit, Center for Rare Respiratory Diseases in Children (RESPIRARE), APHP, Necker-Enfants Malades Hospital, Paris-Cité University, Paris, France.
Anne-Laure RougemontDepartment of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Isabelle VidalDepartment of Pediatrics, Gynecology and Obstetrics, Division of Child and Adolescent Surgery, University Hospital of Geneva, Geneva, Switzerland.
Marie-Luce Bochaton-PiallatDepartment of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Isabelle Ruchonnet-MetraillerDepartment of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland. isabelle.ruchonnet-metrailler@hug.ch.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCongenital pulmonary airways malformations (CPAM) belong to a group of rare congenital lung anomalies whose pathological origin is still mostly unknown. The current research project aims to study the possible role of the underlying mesenchyme in CPAM pathophysiology by comparing data from fetal tissue and healthy lung with CPAM.

methodsTissue samples from CPAM patients and healthy adjacent parts were collected during planned surgical resections. Fetal lung tissue obtained from abortions was also used. The mesenchymal parts of pathological, healthy and fetal lung tissues were analyzed using quantitative proteomic, bulk RNA sequencing and multiplex immunohistochemistry to identify the difference in genes and proteins expressed in CPAM.

resultsWhen compared to healthy adjacent lung tissue, transcriptomic data of CPAM tissue highlighted downregulation of genes implicated in the transforming-growth factor-β and immune-related signaling pathways. Conversely, epithelial-mesenchymal transition genes were upregulated in CPAM, suggesting an abnormal branching associated with abnormal mesenchyme. Quantitative proteomic results showed that the expression of various proteins implicated in muscle differentiation, such as desmin, calponin1 and α-smooth muscle actin, were decreased in CPAM compared to healthy adjacent lung. Multiplex immunostaining confirmed these results with a more significant difference for CPAM type 1 compared to healthy adjacent tissue or to fetal lung. Several pathways known to be crucial in epithelial proliferation, differentiation or branching such as PI3K-AKT-mTOR pathway were dampened.

conclusionOur study reveals the presence of abnormal mesenchyme and muscle in and surrounding cystic tissue. Despite normal lung function during pediatric follow-up, the atypical mesenchyme with possible impaired epithelial-mesenchymal transition could potentially contribute to the development of late adult pathologies such as chronic obstructive pulmonary disease or lung tumors and should be assessed accordingly.

Indexed as

Cystic Adenomatoid Malformation of Lung, CongenitalLungMesodermEpithelial-Mesenchymal TransitionFemaleHumansMaleProteomicsCPAMHumanMesenchymeProteomicTranscriptomicTranslational

Identifiers

PMID40859353
PMCPMC12382140

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.